In Peer Reviewed Journals
Akl EA, Briel M, You JJ, Sun X, Johnston BC, Busse JW, Mulla S, Lamontagne F, Bassler D, Vera C, Alshurafa M, Katsios CM, Zhou Q, Cukierman-Yaffe T, Gangji A, Mills EJ, Walter SD, Cook DJ, Schünemann HJ, Altman DG, Guyatt GH. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ 2012; 344: e2809.
Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med 2012; 10: 51.
Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med 2012; 9: e1001216.
Altman DG, Moher D, Schulz KF. Improving the reporting of randomised trials: the CONSORT Statement and beyond. Stat Med 2012; 31: 2985-2997.
Blanchard-Rohner G, Watt H, Kelly DF, Yu LM, Snape MD, Pollard AJ. Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine. Vaccine 2012; 30: 4153-4159.
Bland JM, Altman DG. Agreed statistics: measurement method comparison. Anesthesiology 2012; 116: 182-185.
Boone D, Halligan S, Mallett S, Taylor SA, Altman DG. Systematic review: Bias in imaging studies – the effect of manipulating clinical context, recall bias and reporting intensity. Eur Radiol 2012; 22: 495-505.
Bouwmeester W, Zuithoff NPA, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW, Altman DG, Moons KGM. Reporting and methods in clinical prediction research: a systematic review. PLoS Med 2012; 9: e1001221.
Campbell MK, Piaggio G, Elbourne DR, Altman DG. CONSORT 2010 Statement: extension to cluster randomised trials. BMJ 2012; 345: e5661.
Caocci G, Efficace F, Ciotti F, Roncarlo MG, Vacca A, Piras E, Littera R, Markous RSD, Collins GS, Ciceri F, Mandelli F, Marktel S, La Nasa G. Health related quality of life in Middle Eastern children with beta-thalassemia. BMC Blood Disorders 2012; 12: 6.
Clutterbuck EA, Lazarus R, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, Pollard AJ. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B CELLS. J Infect Dis 2012; 205: 1408-16.
Collins GS. Validating predictive models for colorectal cancer. Colorectal Cancer 2012; 1: 371-374.
Collins GS, Altman DG. Identifying patients with undetected colorectal cancer: an independent validation of QCancer® (colorectal). Br J Cancer 2012; 107: 260-265.
Collins GS, Altman DG. Identifying women with undetected ovarian cancer: independent validation of QCancer® (ovarian) prediction model. Eur J Cancer Care 2012 Nov 2 [Epub ahead of print].
Collins GS, Altman DG. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 2012; 344: e4181.
Collins GS, Altman DG. Predicting the adverse risk of statin treatment: an independent and external validation of QStatin risk scores in the UK. Heart 2012; 98: 1091-1097.
Collins GS, Altman DG. Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney® scores using a primary care database. Br J Gen Pract 2012; 62: 243-250.
Collins GS, Le Manach Y. Comparing treatment effects between propensity scores and randomized controlled trials: improving conduct and reporting. Eur Heart J 2012; 33: 1867-1869.
Collins GS, Michaëlsson K. Fracture risk assessment: state of the art, methodologically unsound, or poorly reported? Curr Osteoporosis Rep 2012; 10: 199-207.
Collins GS, Moons KGM. Comparing risk prediction models. BMJ 2012; 344: e3186.
Crowther CA, Aghajafari F, Askie LM, Asztalos EV, Brocklehurst P, Bubner TK, Doyle LW, Dutta S, Garite TJ, Guinn DA, Hallman M, Hannah ME, Hardy P, Maurel K, Mazumder P, McEvoy C, Middleton PF, Murphy KE, Peltoniemi OM, Peters D, Sullivan L, Thom EA, Voysey M, Wapner RJ, Yelland L, Zhang S. Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best level of evidence) – study protocol. Syst Rev 2012; 1: 12.
Dekkers OM, Egger M, Altman DG, Vandenbroucke JP. Distinguishing case series from cohort studies. Ann Intern Med 2012; 156: 37-40.
Dinnes J, Hewison J, Altman DG, Deeks JJ. The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer. CMAJ 2012; 184: 169-77.
Eddleston M, Street JM, Self I, Thompson A, King T, Williams N, Naredo G, Dissanayake K, Yu LM, Worek F, John H, Smith S, Thiermann H, Harris JB, Eddie Clutton R. A role for solvents in the toxicity of agricultural organophosphorus pesticides. Toxicology 2012; 294: 94-103.
Ellenberg S, Fernandes RM, Saloojee H, Bassler D, Askie L, Vandermeer B, Offringa M, Van der Tweel I, Altman DG, van der Lee JH for the StaR Child Health Group. Standard 3: Data Monitoring Committees. Pediatrics 2012; 129: S132-S137.
Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, Kieninger D, Prymula R, Dull P, Ypma E, Toneatto D, Kimura A, Pollard AJ; European MenB Vaccine Study Group. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 2012; 307: 573-582.
Greaves P, Clear A, Coutinho R, Wilson A, Matthews J, Owen A, Shanyinde M, Lister TA, Calaminici M, Gribben JG. Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J Clin Oncol 2012 Oct 8 [Epub ahead of print].
Gray R, Sullivan M, Altman DG, Gordon-Weeks AN. Adherence of trials of operative intervention to the CONSORT statement extension for non-pharmacological treatments: a comparative before and after study. Ann R Coll Surg 2012; 94: 388-394.
Groenwold RHH, White IR, Donders ART, Carpenter JR, Altman DG, Moons KGM. Missing covariate data in clinical research: when and when not to use the indicator method. CMAJ 2012; 184: 1265-1269.
Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C; on behalf of the MEADOWS trial researchers. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 379: 528-536.
Hirst A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS One 2012; 7: e35621.
Hopewell S, Simera I. Reporting guidelines: increasing standards in clinical research reporting. Eur J Hosp Pharm 2012; 19: 502-506.
Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ 2012; 344: e4178.
Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O’Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med 2012; 366: 893-903.
Huijbers A, Tollenaar RA, V Pelt GW, Zeestraten EC, Dutton S, McConkey CC, Domingo E, Smit VT, Midgley R, Warren BF, Johnstone EC, Kerr DJ, Mesker WE. The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 2012 Aug 2. [Epub ahead of print]
Independent UK Panel of Breast Cancer Screening [includes Altman DG]. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-1786.
Independent UK Panel of Breast Cancer Screening [includes Altman DG]. The benefits and harms of breast cancer screening: an independent review. A report jointly commissioned by Cancer Research UK and the Department of Health (England), 2012.
Jani A, Jenner L, Ma F, Dutton S, Stevens R, Sharma RA. Referral proformas improve compliance to national colorectal two-week wait targets: Does this impact on cancer detection rates? Colorectal Dis 2012; 14: 1351-1356.
Karamitsos TD, Arnold JR, Pegg TJ, Francis JM, Birks J, Jerosch-Herold M, Neubauer S, Selvanayagam JB. Patients with syndrome X have normal transmural myocardial perfusion and oxygenation: a 3 Tesla cardiovascular magnetic resonance imaging study. Circ Cardiovasc Imaging 2012; 5: 194-200.
Kennedy RH, Francis A, Dutton S, Love S, Pearson S, Blazeby JM, Quirke P, Franks PJ, Kerr DJ. EnROL: A multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme. BMC Cancer 2012; 12: 181.
Khatami A, Snape MD, Davis E, Layton H, John T, Yu LM, Dull PM, Gill CJ, Odrjlin T, Dobson S, Halperin SA, Langley JM, McNeil SA, Pollard AJ. Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations. Vaccine 2012; 30: 2831-2838.
Khatami A, Snape MD, Wysocki J, John TM, Westcar S, Mesaros N, Peddiraju K, Boutriau D, Yu LM, Pollard AJ. Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years: A Follow-Up Study. Pediatr Infect Dis J 2012; 31: 1069-1073.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Vet Clin Pathol 2012; 41: 27-31.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Osteoarthritis Cartilage 2012; 20: 256-260.
Knight SJ, Yau C, Clifford R, Timbs AT, Akha ES, Dréau HM, Burns A, Ciria C, Oscier DG, Pettitt AR, Dutton S, Holmes CC, Taylor J, Cazier JB, Schuh A. Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia. Leukemia 2012; 26: 1564-1575.
Lambe T, Spencer AJ, Mullarkey CE, Antrobus RD, Yu LM, de Whalley P, Thompson BA, Jones C, Chalk J, Kerridge S, Hill AV, Snape MD, Pollard AJ, Gilbert SC. T-Cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent inactivated influenza vaccine. Pediatr Infect Dis J 2012; 31: e86-91.
Le Manach Y, Collins GS, Ibanez C, Goarin JP, Coriat P, Gaudric J, Riou B, Landais P. Impact of perioperative bleeding on the protective effect of β-blockers during infrarenal aortic reconstruction. Anesthesiology 2012; 117: 1203-1211.
Lee CK, Marschner I, Simes J, Voysey M, Egleston BL, Hudes G, de Souza PL. Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus. Clin Cancer Res 2012; 18: 3188-3196.
Lee M, Tajar A, Ravindrarajah R, Pye SR, O'Connor DB, Corona G, O'Connell M, Gielen E, Boonen S, Vanderschueren D, Pendleton N, Finn JD, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS., Huhtaniemi IT, Kula K, Lean ME, Punab M, Wu FC, O'Neill TW. Frailty and sexual health in older European men. J Gerontol A Biol Sci Med Sci 2012 Oct 25 [Epub ahead of print].
Leroy S, Romanello C, Smolkin V, Galetto-Lacour A, Korczowski B, Tuerlinckx D, Rodrigo C, Gajdos V, Moulin F, Pecile P, Halevy R, Gervaix A, Duhl B, Vander Borght T, Prat C, Foix-L’hélias L, Altman DG, Gendrel D, Bréart G, Chalumeau M. Prediction of moderate and high grade vesicoureteral reflux after a first febrile urinary tract infection in children: construction and internal validation of a clinical decision rule. J Urol 2012; 187: 265-271.
Liu J, Sills ES, Yang Z, Salem SA, Rahil T, Collins GS, Liu X, Salem RD. Array comparative genomic hybridization screening in IVF significantly reduces number of embyros available for cryopreservation. Clin Exp Reprod Med 2012; 39: 52-57.
Mallett S, Halligan S, Thompson M, Collins GS, Altman DG. Interpreting diagnostic accuracy studies for patient care. BMJ 2012; 345: e3999.
Metz JA, Hanieh S, Pradhan R, Joshi A, Shakya D, Shrestha L, Shrestha A, Upadhyay B, Kelly SC, John TM, Maharjan BD, Yu LM, Omar O, Borrow R, Findlow J, Kelly DF, Thorson SM, Adhikari N, Murdoch DR, Pollard AJ. Evaluation of Haemophilus influenzae type b vaccine for routine immunization in Nepali infants. Pediatr Infect Dis J 2012; 31: e66-72.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012; 10: 28-55.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 Spiegazione ed elaborazione: linee guida aggiornate per il reporting di trial randomizzati a gruppi paralleli. (In Italian) Evidence 2012; 4: e1000025.
Montoto S, Shaw K, Okosun J, Gandhi S, Fields P, Wilson A, Shanyinde M, Cwynarski K, Marcus R, De Vos J, Young AM, Tenant-Flowers M, Orkin C, Johnson M, Chilton D, Gribben JG, Bower M. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol 2012; 30: 4111-4116.
Moons KGM, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012; 98: 683-690.
Moons KGM, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M. Risk prediction models: II. External validation, model updating and impact assessment. Heart 2012; 98: 691-698.
National Institute for Health and Clinical Excellence [includes Collins GS]. Osteoporosis: assessing the risk of fragility fracture. (Clinical guideline 146.) 2012. www.nice.org.uk/CG146.
Nyangoma SO, Collins SI, Altman DG, Johnson P, Billingham LJ. Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry. Stat Appl Genet Mol Biol 2012; 11: 2.
Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ. B Cell Memory to a Serogroup C Meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody. J Immunol 2012; 189: 2673-2681.
Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 Statement. JAMA 2012; 308: 2594-2604.
Rabar S, Lau R, O’Flynn N, Li L, Barry P; Guideline Development Group [includes Collins GS]. Risk assessment of fragility fractures: summary of NICE guidance. BMJ 2012; 345: e3698.
Rowland R, Pathan AA, Satti I, Poulton ID, Matsumiya MM, Whittaker M, Minassian AM, O’Hara GA, Hamill M, Scott JT, Harris SA, Poyntz HC, Bateman C, Meyer J, Williams N, Gilbert SC, Lawrie AM, Hill AV, McShane H. Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial. Hum Vaccin Immunother 2012; 9 [Epub ahead of print].
Rutter MK, Sattar N, Tajar A, O’Neill TW, Lee DM, Bartfai G, Boonen S, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi I, Kula K, Lean M, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Lowe GD, O'Rahilly S, Morris R, Wu FC, Wannamethee SG. Epidemiological evidence against a role for C-reactive protein causing leptin resistance. Eur J Endocrinol 2012 Oct 9 [Epub ahead of print].
Sarris I, Ioannou C, Chamberlain P, Ohuma E, Roseman F, Hoch L, Altman DG, Papageorghiou AT on behalf of the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). Intra- and interobserver variability in fetal ultrasound measurements. Ultrasound Obstet Gynecol 2012; 39: 266-273.
Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JPA, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JAC. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials: combined analysis of meta-epidemiologic studies. Ann Intern Med 2012; 157: 429-438.
Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JPA, Schulz KF, Beynon R, Welton N, Wood L, Moher D, Deeks JJ, Sterne JAC. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technol Assess 2012; 16(35): 1-82.
Schriger DL, Savage DF, Altman DG. The presentation of continuous outcomes in randomised trials: an observational study. BMJ 2012; 345: e8486.
Schulz KF, Altman DG, Moher D, the CONSORT Group. CONSORT Statement 2010: linee guida aggiornate per il reporting di trial randomizzati a gruppi paralleli. (In Italian) Evidence 2012; 4: e1000024.
Shamseer L, Stevens A, Skidmore B, Turner L, Altman DG, Hirst A, Hoey J, Palepu A, Simera I, Schulz KF, Moher D. Does journal endorsement of reporting guidelines inuence the completeness of reporting of health research? A systematic review protocol. Syst Rev 2012; 1: 24.
Sills ES, Collins GS, Salem SA, Jones CA, Peck AC, Salem RD. Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients. Reprod Biol Endocrinol 2012; 10: 67.
Sinha IP, Altman DG, Beresford MW, Boers M, Clarke M, Craig J, Della Casa Alberighi O, Fernandes RM, Hartling L, Johnston BC, Lux A, Plint A, Tugwell P, Turner M, van der Lee JH, Offringa M, Williamson PR, Smyth RL for the StaR Child Health Group. Standard 5: Selection, measurement, and reporting of outcomes. Pediatrics 2012; 129: S146-S152.
Stewart GB, Altman DG, Askie LM, Duley L, Simmonds MC, Stewart LA. Statistical analysis of individual participant meta-analyses: a comparison of methods and recommendations for practice. PLoS One 2012; 7: e46042.
Sullivan PB, Alder N, Shrestha B, Turton L, Lambert B. Effectiveness of using a behavioural intervention to improve dietary fibre intakes in children with constipation. J Hum Nutr Diet 2012; 25: 33-42.
Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, Bala MM, Bassler D, Mertz D, Diaz-Granados N, Vandvik PO, Malaga G, Srinathan SK, Dahm P, Johnston BC, Alonso-Coello P, Hassouneh B, Walter SD, Heels-Ansdell D, Bhatnagar N, Altman DG, Guyatt GH. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 2012; 344: e1553.
Tajar A, Lee DM, Pye SR, O'Connell MD, Ravindrarajah R, Gielen E, Boonen S, Vanderschueren D, Pendleton N, Finn JD, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Wu FC, O'Neill TW. The association of frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older European men. Age Ageing 2012 Oct 30 [Epub ahead of print].
The Esophageal Adenocarcinoma Genetics Consortium [includes Love S]. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus. Nat Genet 2012; 44: 1131-1136.
Travis SPL, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lémann M, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Bernhardt CA, Mary JY, Sandborn WJ. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012; 61: 535-542.
Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012; 11: MR000030.
Van der Tweel I, Askie L, Vandermeer B, Ellenberg S, Fernandes RM, Saloojee H, Bassler D, Altman DG, Offringa M, van der Lee JH for the StaR Child Health Group. Standard 4: Determining adequate sample sizes. Pediatrics 2012; 129: S138-S145.
Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P. Developing core outcome sets for clinical trials: issues to consider. Trials 2012; 13: 132.
Wright S, Duncombe P, Altman DG. Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach. Trials 2012; 13: 189.
Yaffe J, Montgomery P, Hopewell S, Shepard LD. Empty reviews: a description and consideration of Cochrane systematic reviews with no included studies. PLoS One 2012; 7: e36626.
Yang H, Wu H, Hancock G, Clutton G, Sande N, Xu X, Yan H, Huang X, Angus B, Kuldanek K, Fidler S, Denny TN, Birks J, McMichael A, Dorrell L. The antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ cell decline in HIV-1 infection. J Infect Dis 2012; 206: 552-561.
Yang Z, Liu Y, Collins GS, Salem SA, Liu X, Lyle SS, Peck AC, Sills ES, Salem RD. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 2012; 5: 24.